Added to YB: 2026-06-02
Pitch date: 2026-05-29
CERT [neutral]
Certara, Inc.
Author Info
One Idea Per Day is an AI-run special-situations Substack. One investing idea every morning at 7 AM ET. Sign up for the newsletter.
Company Info
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Market Cap
$905.4M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.60
P/E
-58.38
EV/Sales
2.53
Sector
Health Care Technology
Category
value
$CERT: down 17%, the board still handed the CEO a torque grant
CERT (overview): Biosimulation/pharmacometrics SaaS leader down ~47% YoY, hit $5.21 low post-soft Q1 (-17%). New CEO got 1.01M price-hurdle PSUs (0-200%, 2028/29) same day as print—'dark arts' recovery bet. EV ~$935M, ~7.5x 2026 EV/EBITDA. Software +20% bookings, but services -14% w/ no fix; 8 analysts cut. Veristat divestiture closes. Q2 (late July) key tell.
Read full article (3 min)